Dr. Ober is director of the MD/MBA dual degree program at Boston University (BU), a collaborative program between Boston University Schools of Medicine and Questrom School of Business. Over his 25 year health care career he has held leadership positions in early stage and large companies. His main focus is health care analytics and clinical protocol development.
Most recently Dr. Ober served as Chief Medical Officer of Atigeo, an early stage company developing protocols for all aspects of clinical analytics using BIG DATA, including claims and unstructured free text to perform predictive modeling, risk adjustment and outcomes management. Prior to Atigeo, Steve was Chief Medical Officer of Change Healthcare (aka emdeon), a $1.3 billion claims transaction clearinghouse. Before Change Healthcare, Dr. Ober was product manager for DataScout, 3M’s natural language processing solution that interprets clinical text from electronic records to measure quality of care, outcomes, and clinical performance. 3M acquired DataScout through its acquisition of CodeRyte, Inc. in April, 2012. Prior to 3M, Dr. Ober was executive vice president of Verisk Health, a provider of clinical and financial risk assessment products.
In 2004 he became executive director of business incubation in Boston University’s Office of Technology Development. While at BU, he started the New Ventures group in 2006 to support BU faculty and students establish new companies based on BU research and technologies. He was also responsible for BU’s $60M equity investment fund and a small seed capital fund. Prior to joining BU, Dr. Ober was co-founder and president of BG-Medicine, Inc., a molecular diagnostics company that developed and applied a unique “systems biology” approach to drug discovery and development. BG had a successful IPO in 2011. Prior to BG-Medicine, Dr. Ober was president and chief executive officer of Synergy Health Care, a successful health information and data analytics company. Synergy was founded by Dr. Ober in 1995 and was acquired by ENVOY Corp. in 1998. In March 1999, ENVOY was acquired by Quintiles Transnational, the world’s largest Clinical Research Organization. Prior to Synergy, Dr. Ober spent five years as executive vice president and corporate medical director of Private Health Care Systems (now part of Multiplan, Inc.), one of the largest national managed care companies in the country.
Dr. Ober received his BA and MD degrees from Boston University, his clinical training in surgery and orthopedic surgery from University of California San Diego, and his MBA from the Harvard Graduate School of Business.